Scott Dunseth Myers - Insider Trading & Ownership

Entity
Individual
Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, Washington
Summary
The estimated net worth of Scott Dunseth Myers is at least $5.8 M dollars as of May 28, 2024. Scott Dunseth Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45 M. Scott Dunseth Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $290 K. Scott Dunseth Myers is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. (HARP) stock worth about $64.4 K.
All Insider Reports
All Insider Reports

Ownership of Scott Dunseth Myers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director $5.45 M Apr 12, 2023
DVAX DYNAVAX TECHNOLOGIES CORP Director $290 K May 23, 2024
HARP Harpoon Therapeutics, Inc. Director $64.4 K Mar 11, 2024
RNAC, SELB Cartesian Therapeutics, Inc. Director Nov 13, 2023
TRIL Trillium Therapeutics Inc. Director Nov 17, 2021

Insider Transactions Reported by Scott Dunseth Myers:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership